Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs

T1Covered by 1 source · first reported by MIT News (research) / Quanta / The Conversation at 30 Sept, 09:00 UTC

Some tumor cells develop resistance by amplifying the KRAS gene, while others change their tumor type, MIT researchers have found.

science

Sources

• T1Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugsMIT News (research) / Quanta / The Conversation30 Sept, 09:00